American Society of Gene and Cell Therapy
  • Contact Us

Enjoy the Final Day of #ASGCT22!

  • Annual Meeting
  • Clinical Trials
  • Patient Education
  • Research
    • Landscape Report
    • News
    • Awards
    • New Investigator Center of Educational Resources (NICER)
    • Molecular Therapy
    • Career Center
  • Advocacy
    • Policy Summit
    • Congressional Policy Fellowship
    • The Advocate
    • Research Funding
    • Regulatory Policy
    • Patient Access Overview
    • Responsible Use of Technology
  • Membership
    • Logon
    • Member Dashboard
    • My Profile
    • Membership Directory
    • Become a Member
    • Economy-Based Rates
    • Donate
    • Volunteer
    • The Vector
  • Events
    • ASGCT Annual Meeting
    • ISSCR Symposium
    • ASGCT's Insight Series
    • Professional Development Cafés
    • Policy Summit
    • Global Outreach
    • ASGCT and NORD
    • Past Events
    • Annual Meeting Archives
    • Future Annual Meetings
    • Non-ASGCT Events
  • About
    • Mission & Vision
    • Board & Officers
    • Strategic Plan
    • Standing Committees
    • Scientific Committees
    • Support ASGCT
    • Careers
    • Staff
    • History
    • Bylaws
    • Privacy Policy
Annual Meeting 2018   |   ASGCT News

2018 Annual Meeting By the Numbers

ASGCT Staff - May 31, 2018

The American Society of Gene & Cell Therapy's 22nd Annual Meeting was the Society's largest in history. Check out some of the highlight stats from the May event.

The American Society of Gene & Cell Therapy's 22nd Annual Meeting was the Society's largest in history. Check out some of the highlight stats from the May event.

Related Articles

ASGCT News

ASGCT Statement of Support for the Asian, Asian-American and Pacific Islander Communities

ASGCT Board of Directors - April 27, 2021
ASGCT News

Gene, Cell, & RNA Therapy Landscape: Q1 2021

David M. Barrett, J.D., M.S. - April 15, 2021
ASGCT News

New Diversity and Inclusion Awards Aim to Promote Equity in Gene and Cell Therapy Research

David Barrett, J.D., M.S. - February 26, 2021
ASGCT News

Second mRNA Vaccine for COVID-19 Approved in the U.S.

Stephen J. Russell, M.D., Ph.D. - December 18, 2020

Related Content

  • ASGCT Statement of Support for the Asian, Asian-American and Pacific Islander Communities
  • Gene, Cell, & RNA Therapy Landscape: Q1 2021
  • Diversity and Inclusion Funding Opportunities
  • Second mRNA Vaccine for COVID-19 Approved in the U.S.
  • Approved mRNA Vaccine for COVID-19 is a Milestone for Gene and Cell Therapy
2022

ASGCT 25th Annual Meeting

May 16-19, 2022

Learn More

logo-footer.png

20800 Swenson Dr.
Suite 300
Waukesha, WI 53186

  • About
  • Membership
  • Annual Meeting
  • Journal
  • Education
  • Advocacy
  • Research
  • Privacy Policy

Connect with ASGCT

Phone: 414.278.1341
info@asgct.org

© 2000-2022 All rights reserved. American Society of Gene & Cell Therapy. 

Kentico CMS Development by Reason One | Powered by Kentico

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.